Financials
Financial year 2025
Robust Bioprocess Design from Gent, company number BE0768765679, closed financial year 2025 with a result of € 38,761 after tax. For that financial year Robust Bioprocess Design recorded a gross margin of € 53,270 and equity of € 5,000. Compared with financial year 2024, the result moved from € 64,055 to € 38,761. The company is profitable. The buffer shrank hard: equity is 74 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 2, 2026.
€ 5,000
▼ 74% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 38,761
▼ 39% vs 2024
Profit after tax over the fiscal year.
€ 27,812
▼ 47% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 52,816 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 340
▼ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,756
▼ 40% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 87,505 | € 53,270 | ▼ 39% |
| Profit after taxes | € 64,055 | € 38,761 | ▼ 39% |
| Equity | € 19,055 | € 5,000 | ▼ 74% |
| Total debts | € 63,640 | € 61,083 | ▼ 4% |
| Cash | € 52,806 | € 27,812 | ▼ 47% |
| Retained profit | € 14,055 | € 0 | ▼ 100% |
| Dividend | € 262,142 | € 52,816 | ▼ 80% |
| Balance sheet total | € 82,695 | € 66,083 | ▼ 20% |
Key figures of Robust Bioprocess Design, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Robust Bioprocess Design?
What happened at Robust Bioprocess Design in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 38,761 (▼ 39% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 64,055 profit in 2024 to € 38,761 profit in 2025.
Paid € 32,999 in corporate taxes since 2024.
Best year ever: 2024, with € 64,055 profit.
Paid out € 314,958 in dividends to the owners in total.
Management
Behind Robust Bioprocess Design is Bernd Everaert.
Directors
According to the 2025 annual accounts
Bernd Everaert
Director
Establishments
Establishment units
Physical locations of this company
Rode-Kruisstraat 5
9050 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0768.765.679
- VAT number
- BE 0768.765.679
- Registered office
- Rode-Kruisstraat 5, 9050 Gent
- Names & denominations
- Robust Bioprocess Design · RBIOPD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 May 2021
- Peppol
- Active · Active since 19 Dec 2024
- Activities · NACE
Overige zakelijke dienstverlening, neg
Speur- en ontwikkelingswerk op biotechnologisch gebied
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Markt- en opinieonderzoek
Arbeidsbemiddeling
Beroepsopleiding
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering